Business Context and Reporting Period
Company: Superior Group of Companies, Inc. (SGC)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2024
Business Overview: The Company operates three segments: Branded Products (customized merchandising and uniforms), Healthcare Apparel (scrubs and protective apparel), and Contact Centers (outsourced business process services). The Company is an accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric (in thousands) | Q3 2024 | Q3 2023 | 9M 2024 | 9M 2023 |
|---|---|---|---|---|
| Net Sales | $149,690 | $136,126 | $420,268 | $396,061 |
| Gross Margin | $60,546 (40.4%) | $53,198 (39.1%) | $166,618 (39.6%) | $147,902 (37.3%) |
| Net Income | $5,403 | $3,114 | $9,915 | $5,215 |
| Diluted EPS | $0.33 | $0.19 | $0.60 | $0.32 |
| EBITDA | $11,654 | $9,253 | $26,844 | $23,584 |
| Cash from Operations (9M) | $24,497 | $59,388 | ||
| Total Debt (Long-term + Current) | $84,380 | $93,477 | ||
| Cash and Equivalents | $18,373 | $19,896 |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net sales increased 10.0% in Q3 2024 and 6.1% for the nine months ended September 30, 2024, compared to the prior year. Growth was driven by all three segments, with Branded Products up 10.8% (Q3) and Healthcare Apparel up 11.4% (Q3).
- Profitability Expansion: Net income surged 73.5% in Q3 and 90.1% for the nine-month period. This was primarily due to improved gross margins (driven by sourcing mix and pricing) and a significant reduction in interest expense.
- Interest Expense Reduction: Interest expense decreased 36.3% in Q3 and 36.1% for the nine months, attributed to lower weighted average outstanding borrowings and a decrease in the weighted average interest rate (from 7.4% to 6.3% in Q3).
- Operating Cash Flow: Net cash provided by operating activities for the nine months ended September 30, 2024, was $24.5 million, a decrease from $59.4 million in the prior year period. This decline was due to working capital changes, specifically cash outflows for inventories, contract assets, and accounts payable.
Guidance, Outlook, Risks, and Unusual Items
- Capital Allocation: The Board approved a new $10 million stock repurchase plan in August 2024, replacing the prior plan. The Company repurchased 451,786 shares in Q3 2024. Cash dividends of $0.14 per share were declared for the quarter.
- Internal Controls: The Company disclosed a continuing material weakness in internal control over financial reporting related to segregation of duties and change management in the Contact Centers segment's IT systems. Remediation efforts are ongoing but not yet complete.
- Geopolitical Risks: The Company highlighted risks associated with civil unrest in Haiti, where it operates manufacturing facilities for the Healthcare Apparel segment. Disruptions could impact production and supply chains.
- Unusual Items: A $2.4 million reduction in liabilities occurred due to the expiration of written put options in the second quarter of 2024. Additionally, a $260,000 impairment charge was recorded in Q3 2024.
- Outlook: Management expects to continue paying dividends and believes current cash levels and credit facility availability are sufficient for the next 12 months. No specific forward-looking financial guidance was provided in this filing.
Investor Verification Checklist
- Internal Control Remediation: Verify the timeline and progress of remediation for the material weakness in the Contact Centers segment.
- Haiti Operations: Monitor news regarding civil unrest in Haiti and its potential impact on the Healthcare Apparel segment's supply chain.
- Debt Covenants: Confirm continued compliance with the Credit Agreement's fixed charge coverage ratio (1.25:1) and net leverage ratio (4.0:1).
- Share Repurchase Activity: Track the execution of the new $10 million repurchase program and its impact on share count.
- Working Capital Trends: Analyze the drivers behind the significant decrease in operating cash flow compared to the prior year, specifically regarding inventory and contract asset management.